NEW YORK , Aug. 7, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2024 , and provide a corporate update, at 8:30 a.
m. Eastern Time on Wednesday , August 14, 2024. BrainStorm's Chief Executive Officer, Chaim Lebovits, will present a corporate update after which participant questions will be answered.
Joining Mr. Lebovits to answer investment community questions will be Haro Hartounian, Ph.D.
, Chief Operating Officer, Bob Dagher , M.D., Chief Medical Officer, and Alla Patlis , CPA, MBA, Interim Chief Financial Officer.
Participants are encouraged to submit their questions in advance of the call by sending them to: [email protected] . Questions should be submitted by 5:00 p.m.
Eastern Time on Monday, August 12, 2024 . The investment community may participate in the conference call by dialing the following numbers: Participant Numbers: Toll Free: 877-545-0523 International: 973-528-0016 Participant Access Code: 308245 Webcast URL : https://www.webcaster4.
com/Webcast/Page/2354/51009 The replay of the conference call can be accessed by dialing the numbers below and will be available for 14 days. Replay Numbers: Toll Free: 877-481-4010 International: 919-882-2331 Replay Passcode: 51009 About BrainStorm Cell Therapeutics Inc . BrainStorm Cell Th.